An Integrative Approach to Veterinary Ophthalmology
A series of 4 webinars presented by Dr Carmen Colitz DVM, PhD, Diplomate ACVO
This series of 4 lectures is $120 full fee and $90 for CIVT Members.
RACE Accredited: 70% pass on short quiz required for each lecture.
Progressive Retinal Atrophy: New Progress in a Hopeless Disease - Saving Vision in PRA Dogs by Saving Cones with Antioxidant Support
PRA, is the term for many inherited retinal degenerative diseases affecting numerous breeds of dogs, both pure and mixed. The majority of PRA diseases affect the rod photoreceptors of the retina causing night vision loss initially, followed by loss of day vision and complete blindness. Typical PRA is a disease caused by a mutation in the rod photoreceptors; cone death subsequently occurs due to excessive oxygen exposure in the face of rod loss through a cascade of oxidative stress mechanisms -antioxidant supplementation can protect cones and their function.
NOW AVAILABLE as a recording. See a preview.
The Blind Diabetic Dog: No Longer the Inevitable Outcome - Preventing Vision Loss by Preventing Cataractogenesis with Integrative Support
This webinar will provide an understanding of the known causes and recommended prevention methods of canine and feline cataract formation. Eighty percent of dogs with diabetes mellitus will develop cataracts within 16 months of diagnosis, the majority of the remaining 20% will follow. Discover how integrative supportive therapy can prevent the development of cataract.
NOW AVAILABLE as a recording.
Eyes Behaving Badly: Fighting Immune-mediated Ocular Disease with Integrative Medical Strategies
Inflammation and immunologic reactions and their sequelae are critical and serious issues when considering a therapeutic plan for ocular diseases. The eye is unique such that tissue damage resulting from inflammation and disease may cause significant loss of function in the eye, whereas, these same entities cause negligible damage elsewhere in the body. The eye is not forgiving to disease and rapid control of inflammation is necessary to retain the eye and its function i.e. sight.
The ocular surface mucosal immune system works to fight invading organisms while minimizing damage to the cell layers. This entails the combination of both the innate immune system and the adaptive immune system. This webinar will focus on clinical immune-mediated diseases commonly seen and how integrative approaches are used with traditional therapy.
Now available as a recording.
New Hope for the Doomed Eye: Fighting Glaucoma with Natural Neuroprotection
Glaucoma is a common and painful cause of blindness that is most prevalent in many dogs. Nearly 0.9% of pure bred dogs in North America are affected. Glaucoma comprises a group of diseases that ultimately results in optic nerve head circulation damage, retinal ganglion cell death, and irreversible blindness. The objective of this lecture is to outline the differences between primary and secondary glaucoma, acute and chronic glaucoma and learn treatment options for all stages of glaucoma.
Live: August 11 2016 at 5pm PDT - California.
This series of 4 lectures is $120 full fee and $90 for CIVT Members.
Dr Carmen Colitz, DVM, PhD, Diplomate of the American College of Veterinary Ophthalmologists
Dr. Carmen Colitz has a passion for helping animals which exudes not only from her work as one of the world’s leading veterinary ophthalmologists, but also at her home that she shares with nine pets.
“My career journey naturally evolved. In vet school, I knew I wanted to practice ophthalmology, and I was inspired by the practice of cataract surgery and the positive outcomes I saw in animals,” she says. “Since then, I have been singularly focused on improving the eye health of dogs, cats and also of marine mammals through both research and clinical work.”
Dr. Colitz earned her Doctorate of Veterinary Medicine and a Ph.D. in Comparative and Experimental Medicine from the University of Tennessee in 1993 and 1996, respectively. Her research involved the study of ocular embryology and molecular biology of cancer. She became a board-certified veterinary ophthalmologist in 1999. During her residency training, Dr. Colitz completed a one-year post-doctoral research project and successfully competed for a five-year grant from the National Institutes of Health Eye Institute.
Dr. Colitz worked for two years at the Louisiana State University School of Veterinary Medicine, and then spent five years at The Ohio State University’s veterinary teaching hospital as a clinician and researcher. Dr. Colitz discovered telomerase (a cancer protein) in the normal and cataractous lens, and researched the molecular biology of cataractogenesis and posterior capsular opacification (PCO). PCO is the leading post-operative complication of cataract surgery and over the past eleven years, her research has centered on molecular approaches to prevent this post-operative complication. She was also involved in research to evaluate lutein and grapeseed extract as well as other antioxidants in their anti-cataractogenic and anti-PCO effects. Dr. Colitz’s additional research interests include corneal wound healing, infectious diseases and ocular cancers. Dr Colitz has written or co-written over 60 peer reviewed publications and 19 book chapters and is Past-President of the American College of Veterinary Ophthalmologists.
Over the course of her career, Dr. Colitz has worked with numerous animal species and has performed thousands of ophthalmologic surgeries on both companion pets, marine mammals, and other exotic species, including eels. In 2009, she founded Aquatic Animal Eye Care, LLC. Aquatic Animal Eye Care’s mission was to understand and improve the ocular diseases that affect marine mammals, penguins and fishes both under human care and in the wild. She has performed over 200 cataract extractions in seals and sea lions, allowing them to return to more productive and enriched lives. She has authored or co-authored 8 manuscripts and one book chapter specifically about pinnipeds and their eye problems. Other large-scale multi-facility projects are presently underway and will be published in the near future. Recently, she has also been involved in the formulation of natural supplements to support eye health in both canines and marine mammals.
In 2006, Dr. Colitz began collaborating with Dr. Terri McCalla, a fellow board certified veterinary ophthalmologist, and Debby Smith, chemist and compounding pharmacist, in the development of an innovative vision supplement for canines. The team formed Animal HealthQuest, LLC as a company dedicated to providing unique, high quality nutritional supplements for domestic animals to improve the quality of life for pets and their owners. In 2010, Animal HealthQuest introduced its first product, Ocu-GLO RxTM, to the market. Ocu-GLO Rx is the first ocular supplement specifically designed to meet the needs of canine eyes. It combines 12 different natural antioxidants including grapeseed extract, lutein and omega-3 fatty acids to synergistically support canine eye health and may help slow the progression of degenerative eye diseases. To learn more about Ocu-GLO RxTM, go to www.ocuglo.com.
Dr. Colitz also worked with Dr. Johanna Mejia-Fava in the development of Eye-SEATM, a pharmaceutical grade nutraceutical specifically formulated for marine mammal eye support. The 10 different antioxidants in Eye-SEATM support all structures of the eye in specific and non-specific ways.
Dr. Carmen Colitz is a Consulting Veterinarian for Animal Necessity, LLC.